Guilherme oversees IFPMA’s activities on government outreach, innovation, intellectual property, trade, and alliance-building.
He is an expert in global health diplomacy, with emphasis on policies and processes that enable pharmaceutical innovation to thrive. He leads IFPMA engagement on multiple ongoing multilateral negotiations in Geneva and New York.
Before joining IFPMA, Guilherme was European liaison for the Brazilian start-up “Green Value” helping to promote tools for financial analysis of forest-based initiatives on several environmental projects focusing on carbon credits trading under the Kyoto Protocol.
Guilherme holds a master’s and a bachelor’s degree in Economic History from the University of Geneva as well as a bachelor’s in Social Sciences from the Federal University of Minas Gerais, Brazil.
More from Guilherme
Is an extension of the TRIPS waiver needed for COVID-19 tools?
Evidence shows that progress made in sharing IP through voluntary agreements, combined with tiered-pricing and not-for-profit arrangements for low- and middle-income countries has led to production of COVID-19 therapeutics exceeding demand for all disease severity levels and in all patient settings.
Celebrating World Intellectual Property Day
Today we celebrate the World Intellectual Property Day to praise the invaluable contributions made by innovators across the globe. Since the dawn of time, mankind has applied innovation to solve problems and live better, healthier and more plentiful lives. Apart from human creativity and passion, IP has been one of the most powerful forces fostering...